Shu Mao

439 total citations
18 papers, 231 citations indexed

About

Shu Mao is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Computational Theory and Mathematics. According to data from OpenAlex, Shu Mao has authored 18 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Computational Theory and Mathematics. Recurrent topics in Shu Mao's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Computational Drug Discovery Methods (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Shu Mao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Computational Drug Discovery Methods (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Shu Mao collaborates with scholars based in China, United States and Spain. Shu Mao's co-authors include Rui Liu, Xiaolong Qian, Wenqian Zhang, Leming Shi, Zhihua Lin, Donna L. Mendrick, Tingting Du, Huixiao Hong, Peng Zhou and Weida Tong and has published in prestigious journals such as PLoS ONE, Molecular Cancer Therapeutics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Shu Mao

16 papers receiving 224 citations

Peers

Countries citing papers authored by Shu Mao

Since Specialization

Citations

This map shows the geographic impact of Shu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Mao more than expected).

Fields of papers citing papers by Shu Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Mao. The network helps show where Shu Mao may publish in the future.

Co-authorship network of co-authors of Shu Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Mao. A scholar is included among the top collaborators of Shu Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Mao. Shu Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Identification of potential SPHK1 inhibitors based on structural optimization by molecular simulation 2025 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), Na Yu, Shu Mao	1
2	Molecular dynamics simulation-driven focused virtual screening and experimental validation of Fisetin as an inhibitor of Helicobacter pylori HtrA protease 2025 ·Molecular Diversity ·(unknown), (unknown), (unknown), Yan Shen, Kui Gu, (unknown), Yuanqiang Wang, Shu Mao, Rui Zhang, (unknown)	0
3	Virtual Screening and Multi-targets Investigation of Novel Diazine Derivativesas Potential Xanthine Oxidase Inhibitors Based on QSAR, MolecularDocking, ADMET Properties, Dynamics Simulation and NetworkPharmacology 2023 ·Medicinal Chemistry ·(unknown), (unknown), Yaru Liu, Zhiping Zhang, (unknown), Shu Mao, Zhihua Lin	6
4	Underwater Wireless Optical Communication Using Diversity Reception and Pruned-Term-Based Nonlinear DFE 2023 ·Chao Fei, Shu Mao, (unknown), (unknown), (unknown), (unknown), Tianyi Zhang, Xiaojian Hong, Yuan Wang, (unknown), Guowu Zhang, Shiyin Li	0
5	Discovery of novel tubulin polymerization inhibitors by utilizing 3D-QSAR, molecular docking and molecular dynamics simulation 2022 ·New Journal of Chemistry ·(unknown), Rui Zhang, (unknown), Na Yu, (unknown), Shu Mao, Yan Shen	6
6	Abstract P134: Novel EGFRvIII-selective antibody-drug conjugate REGN3124-PBD is strongly efficacious against orthotopic glioblastoma multiforme patient derived xenografts 2021 ·Molecular Cancer Therapeutics ·Marcus P. Kelly, Sosina Makonnen, Carlos Hickey, Shu Mao, Feng Zhao, Arthur Kunz, Frank J. Delfino, Thomas Nittoli, Dangshe Ma, William C. Olson, Gavin Thurston, Jessica R. Kirshner	1
7	Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids 2020 ·Bioorganic & Medicinal Chemistry ·Thomas Nittoli, Frank J. Delfino, Marcus P. Kelly, (unknown), (unknown), Arthur Kunz, Zhaoyuan Chen, Shu Mao, Jing Shan, Elizabeth Navarro, Feng Zhao, Sosina Makonnen, Carlos Hickey, (unknown), William C. Olson, Jessica R. Kirshner, Gavin Thurston, Nicholas Papadopoulos	4
8	Invited paper: Kinetic diffusion multiple: A high-throughput approach to screening the composition-microstructure-micromechanical properties relationships 2018 ·Calphad ·Shu Mao, Chuanyun Wang, Na Li, Jingya Wang, Yi Chen, Guanglong Xu, Yanhua Guo, Yuwen Cui	9
9	Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy 2017 ·Phytomedicine ·Ao Li, Xiaoxun Zhang, Shu Mao, Mingjun Wu, Jun Wang, Jingyao Zhang, (unknown), Peng Li, Yitao Wang	49
10	Alert correlation analysis based on attack path graph 2017 ·(unknown), (unknown), Peng Zhang, Shu Mao, Hongbin Wu	1
11	Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses 2016 ·PLoS ONE ·Shu Mao, (unknown), (unknown), (unknown), Zhihua Lin	27
12	Molecular Docking to Identify Associations Between Drugs and Class I Human Leukocyte Antigens for Predicting Idiosyncratic Drug Reactions 2015 ·Combinatorial Chemistry & High Throughput Screening ·Heng Luo, Tingting Du, Peng Zhou, Lun Yang, Mei Hu, (unknown), Wenqian Zhang, Shu Mao, Weida Tong, Leming Shi, Donna L. Mendrick, Huixiao Hong	66
13	Quantitative Prediction of Class I MHC/Epitope Binding Affinity Using QSAR Modeling Derived from Amino Acid Structural Information 2015 ·Combinatorial Chemistry & High Throughput Screening ·Yuanqiang Wang, Pengpeng Zhou, Yong Lin, Shu Mao, (unknown), Qingyou Xia, Zhihua Lin	10
14	QSAR Study on MHC Class I A Alleles Based on the Novel Parameters of Amino Acids 2011 ·Protein and Peptide Letters ·Juan Wang, Xiaoyu Wang, Shu Mao, Yuanqiang Wang, (unknown), Li Wang, (unknown), Zhihua Lin	4
15	Predicting the Activity of ACE Inhibitory Peptides with a Novel Mode of Pseudo Amino Acid Composition 2011 ·Protein and Peptide Letters ·Shu Mao, (unknown), (unknown), Yuanqiang Wang, (unknown), Li Wang, Zhihua Lin	18
16	Research on anti-money laundering based on core decision tree algorithm 2011 ·Rui Liu, Xiaolong Qian, Shu Mao, (unknown)	27
17	[Chemical structural characterization of some components from essential oil of Rosa banksiae for estimation and prediction of their retention time]. 2008 ·PubMed ·(unknown), Mei Hu, Shu Mao, Limin Liao, (unknown), Zhiliang Li	1
18	ESTABLISHMENT AND APPLICATION OF A NEW MECHANICAL UNIT FOR CELL CULTURE 2002 ·Shu Mao	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact